overnment regulatory bodies, international organizations, healthcare professionals, industry, consumers, and other stakeholders, to gather information regarding nanoscale materials used or that could be used in FDA-regulated products;Consider appropriate vehicles for communicating with the public about the use of nanoscale materials in FDA-regulated products; andSubmit its initial findings and rec